Product NDC: | 65162-643 |
Proprietary Name: | Flecainide Acetate |
Non Proprietary Name: | Flecainide Acetate |
Active Ingredient(s): | 150 mg/1 & nbsp; Flecainide Acetate |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 65162-643 |
Labeler Name: | Amneal Pharmaceuticals, LLC |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA075442 |
Marketing Category: | ANDA |
Start Marketing Date: | 20091201 |
Package NDC: | 65162-643-11 |
Package Description: | 1000 TABLET in 1 BOTTLE (65162-643-11) |
NDC Code | 65162-643-11 |
Proprietary Name | Flecainide Acetate |
Package Description | 1000 TABLET in 1 BOTTLE (65162-643-11) |
Product NDC | 65162-643 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Flecainide Acetate |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 20091201 |
Marketing Category Name | ANDA |
Labeler Name | Amneal Pharmaceuticals, LLC |
Substance Name | FLECAINIDE ACETATE |
Strength Number | 150 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Antiarrhythmic [EPC] |